NGM Insider Trading

Insider Ownership Percentage: 35.90%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

NGM Biopharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at NGM Biopharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

NGM Biopharmaceuticals Share Price & Price History

Current Price: $1.59
Price Change: Price Decrease of -0.03 (-1.85%)
As of 03/28/2024 01:00 AM ET

This chart shows the closing price history over time for NGM up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

NGM Biopharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/30/2023Group L P ColumnDirectorBuy7,542$5.00$37,710.00750,501View SEC Filing Icon  
1/23/2023Group L P ColumnDirectorBuy9,900$5.00$49,500.00742,959View SEC Filing Icon  
1/19/2023Group L P ColumnDirectorBuy37,639$5.00$188,195.00732,559View SEC Filing Icon  
1/17/2023Jin-Long ChenInsiderSell85,082$5.15$438,172.30908,893View SEC Filing Icon  
1/12/2023Group L P ColumnDirectorBuy5,378$4.95$26,621.10694,920View SEC Filing Icon  
1/10/2023Group L P ColumnDirectorBuy100,070$4.84$484,338.80480,542View SEC Filing Icon  
12/12/2022Group L P ColumnDirectorBuy300$4.98$1,494.00380,472View SEC Filing Icon  
11/21/2022Group L P ColumnDirectorBuy35,997$5.00$179,985.00375,842View SEC Filing Icon  
11/3/2022Group L P ColumnDirectorBuy104,090$4.99$519,409.10304,787View SEC Filing Icon  
10/27/2022David V GoeddelDirectorBuy76,877$4.86$373,622.22200,697View SEC Filing Icon  
10/25/2022Group L P ColumnDirectorBuy51,046$4.75$242,468.5051,046View SEC Filing Icon  
10/17/2022David V GoeddelDirectorBuy50,000$3.18$159,000.00130,000View SEC Filing Icon  
6/9/2022Group L P ColumnDirectorBuy984,161$13.50$13,286,173.502,650,177View SEC Filing Icon  
6/2/2022Group L P ColumnDirectorBuy34,200$13.03$445,626.001,698,493View SEC Filing Icon  
5/31/2022Group L P ColumnDirectorBuy61,806$13.47$832,526.821,576,458View SEC Filing Icon  
5/26/2022Group L P ColumnDirectorBuy20,201$13.49$272,511.491,514,071View SEC Filing Icon  
5/24/2022Group L P ColumnDirectorBuy17,828$13.37$238,360.361,452,674View SEC Filing Icon  
5/19/2022Group L P ColumnDirectorBuy20,666$13.25$273,824.501,417,028View SEC Filing Icon  
5/17/2022Group L P ColumnDirectorBuy89,049$13.42$1,195,037.581,336,461View SEC Filing Icon  
5/11/2022Group L P ColumnDirectorBuy83,175$11.25$935,718.751,012,753View SEC Filing Icon  
5/9/2022Group L P ColumnDirectorBuy83,175$10.79$897,458.25902,090View SEC Filing Icon  
12/6/2021Jin-Long ChenInsiderSell15,000$18.21$273,150.00View SEC Filing Icon  
11/18/2021David J. WoodhouseCEOSell15,000$20.02$300,300.00View SEC Filing Icon  
11/15/2021Jin-Long ChenInsiderSell30,000$19.73$591,900.00View SEC Filing Icon  
10/11/2021Jin-Long ChenInsiderSell15,000$20.41$306,150.00View SEC Filing Icon  
10/5/2021Hsiao D. LieuSVPSell2,000$22.00$44,000.00View SEC Filing Icon  
9/13/2021Jin-Long ChenInsiderSell15,000$26.03$390,450.00View SEC Filing Icon  
8/9/2021Jin-Long ChenInsiderSell15,000$24.46$366,900.00View SEC Filing Icon  
4/12/2021Jin-Long ChenInsiderSell25,000$24.65$616,250.00945,005View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for NGM Biopharmaceuticals (NASDAQ:NGM)

75.74% of NGM Biopharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at NGM by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

NGM Biopharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/11/2024Vanguard Group Inc.2,770,574$2.38M0.0%+0.3%3.349%Search for SEC Filing on Google Icon
3/1/2024Goldman Sachs Group Inc.110,682$95K0.0%-59.5%0.134%Search for SEC Filing on Google Icon
2/16/2024GSA Capital Partners LLP334,473$0.29M0.0%+56.5%0.404%Search for SEC Filing on Google Icon
2/15/2024Barclays PLC91,192$78K0.0%+134.7%0.110%Search for SEC Filing on Google Icon
2/15/2024Vanguard Group Inc.2,770,574$2.38M0.0%+0.3%3.350%Search for SEC Filing on Google Icon
2/15/2024Bridgeway Capital Management LLC195,000$0.17M0.0%-29.1%0.236%Search for SEC Filing on Google Icon
2/13/2024Goldman Sachs Group Inc.110,682$95K0.0%-59.5%0.134%Search for SEC Filing on Google Icon
2/7/2024Dimensional Fund Advisors LP154,456$0.13M0.0%-25.7%0.187%Search for SEC Filing on Google Icon
2/7/2024BNP Paribas Financial Markets220,656$0.19M0.0%+154.6%0.267%Search for SEC Filing on Google Icon
2/5/2024Russell Investments Group Ltd.43,598$37K0.0%-64.9%0.053%Search for SEC Filing on Google Icon
1/31/2024Federated Hermes Inc.345,381$0.30M0.0%-41.0%0.418%Search for SEC Filing on Google Icon
1/30/2024Mackenzie Financial Corp62,964$54K0.0%+40.3%0.076%Search for SEC Filing on Google Icon
1/5/2024Exchange Traded Concepts LLC107,019$92K0.0%+34.0%0.129%Search for SEC Filing on Google Icon
12/18/2023Vanguard Group Inc.2,761,102$2.95M0.0%-1.2%3.338%Search for SEC Filing on Google Icon
12/1/2023Euclidean Capital LLC992,168$1.06M0.2%+32.9%1.199%Search for SEC Filing on Google Icon
11/21/2023Walleye Capital LLC145,969$0.16M0.0%-40.9%0.176%Search for SEC Filing on Google Icon
11/17/2023Jacobs Levy Equity Management Inc.558,604$0.60M0.0%-3.5%0.675%Search for SEC Filing on Google Icon
11/16/2023Tudor Investment Corp Et Al25,147$27K0.0%-37.1%0.030%Search for SEC Filing on Google Icon
11/15/2023GSA Capital Partners LLP213,676$0.23M0.0%-33.4%0.258%Search for SEC Filing on Google Icon
11/14/2023Jasper Ridge Partners L.P.303,492$0.33M0.0%-12.9%0.367%Search for SEC Filing on Google Icon
11/14/2023Tower Research Capital LLC TRC 27,898$30K0.0%+589.2%0.034%Search for SEC Filing on Google Icon
11/14/2023Pale Fire Capital SE33,800$36K0.0%N/A0.041%Search for SEC Filing on Google Icon
11/13/2023Algert Global LLC37,390$40K0.0%-72.8%0.045%Search for SEC Filing on Google Icon
11/13/2023Acadian Asset Management LLC1,193,971$1.28M0.0%+4.8%1.443%Search for SEC Filing on Google Icon
11/13/2023FMR LLC61,713$66K0.0%+28.2%0.075%Search for SEC Filing on Google Icon
10/25/2023Mackenzie Financial Corp44,880$48K0.0%+135.1%0.054%Search for SEC Filing on Google Icon
10/18/2023Exchange Traded Concepts LLC79,882$85K0.0%+100.6%0.097%Search for SEC Filing on Google Icon
8/22/2023Virginia Retirement Systems ET AL15,400$40K0.0%N/A0.019%Search for SEC Filing on Google Icon
8/21/2023California State Teachers Retirement System54,196$0.14M0.0%+35.2%0.066%Search for SEC Filing on Google Icon
8/16/2023Nuveen Asset Management LLC781,337$2.02M0.0%+1.6%0.945%Search for SEC Filing on Google Icon
8/15/2023Alliancebernstein L.P.73,290$0.19M0.0%+16.7%0.089%Search for SEC Filing on Google Icon
8/15/2023Wells Fargo & Company MN17,064$44K0.0%+112.2%0.021%Search for SEC Filing on Google Icon
8/15/2023Walleye Capital LLC246,963$0.64M0.0%-17.5%0.299%Search for SEC Filing on Google Icon
8/15/2023XTX Topco Ltd43,445$0.11M0.0%-29.4%0.053%Search for SEC Filing on Google Icon
8/15/2023Goldman Sachs Group Inc.236,736$0.61M0.0%+24.1%0.286%Search for SEC Filing on Google Icon
8/15/2023Caxton Associates LP32,352$84K0.0%-22.3%0.039%Search for SEC Filing on Google Icon
8/14/2023PDT Partners LLC28,895$75K0.0%-61.3%0.035%Search for SEC Filing on Google Icon
8/14/2023State of Wisconsin Investment Board165,668$0.43M0.0%+14.6%0.200%Search for SEC Filing on Google Icon
8/14/2023State Street Corp856,566$2.22M0.0%+15.9%1.036%Search for SEC Filing on Google Icon
8/14/2023Nuveen Asset Management LLC781,337$2.02M0.0%+1.6%0.945%Search for SEC Filing on Google Icon
8/14/2023Prelude Capital Management LLC10,416$27K0.0%N/A0.013%Search for SEC Filing on Google Icon
8/11/2023Renaissance Technologies LLC252,600$0.65M0.0%-23.3%0.305%Search for SEC Filing on Google Icon
8/11/2023Credit Suisse AG49,704$0.13M0.0%+32.3%0.060%Search for SEC Filing on Google Icon
8/11/2023BlackRock Inc.4,633,005$12M0.0%+12.8%5.601%Search for SEC Filing on Google Icon
8/11/2023Franklin Resources Inc.33,438$87K0.0%N/A0.040%Search for SEC Filing on Google Icon
8/11/2023Geode Capital Management LLC850,956$2.20M0.0%+7.6%1.029%Search for SEC Filing on Google Icon
8/11/2023JPMorgan Chase & Co.546,877$1.42M0.0%+1.3%0.661%Search for SEC Filing on Google Icon
8/10/2023MetLife Investment Management LLC21,464$56K0.0%+168.1%0.026%Search for SEC Filing on Google Icon
8/10/2023Russell Investments Group Ltd.113,195$0.29M0.0%+153.6%0.137%Search for SEC Filing on Google Icon
8/10/2023Charles Schwab Investment Management Inc.271,688$0.70M0.0%-16.4%0.328%Search for SEC Filing on Google Icon
8/10/2023Citigroup Inc.15,949$41K0.0%+830.5%0.019%Search for SEC Filing on Google Icon
8/9/2023Dimensional Fund Advisors LP438,533$1.14M0.0%-5.5%0.530%Search for SEC Filing on Google Icon
8/9/2023Swiss National Bank98,200$0.25M0.0%+59.2%0.119%Search for SEC Filing on Google Icon
8/7/2023Acadian Asset Management LLC1,138,843$2.95M0.0%+21.4%1.383%Search for SEC Filing on Google Icon
8/3/2023Mackenzie Financial Corp19,092$52K0.0%+49.4%0.023%Search for SEC Filing on Google Icon
8/3/2023Bank of New York Mellon Corp139,536$0.36M0.0%+5.2%0.169%Search for SEC Filing on Google Icon
8/1/2023Arizona State Retirement System12,676$33K0.0%N/A0.015%Search for SEC Filing on Google Icon
7/25/2023Raymond James Financial Services Advisors Inc.13,335$35K0.0%-62.3%0.016%Search for SEC Filing on Google Icon
7/25/2023Raymond James & Associates22,233$58K0.0%-22.2%0.027%Search for SEC Filing on Google Icon
7/20/2023Exchange Traded Concepts LLC39,816$0.10M0.0%N/A0.048%Search for SEC Filing on Google Icon
7/19/2023Teacher Retirement System of Texas12,193$32K0.0%N/A0.015%Search for SEC Filing on Google Icon
5/22/2023Putnam Investments LLC44,848$0.18M0.0%+48.8%0.054%Search for SEC Filing on Google Icon
5/22/2023Ameriprise Financial Inc.83,612$0.34M0.0%+72.8%0.102%Search for SEC Filing on Google Icon
5/18/2023JPMorgan Chase & Co.539,862$2.20M0.0%-4.7%0.655%Search for SEC Filing on Google Icon
5/18/2023New York State Common Retirement Fund10,146$41K0.0%-61.6%0.012%Search for SEC Filing on Google Icon
5/16/2023Jane Street Group LLC65,318$0.27M0.0%+105.9%0.079%Search for SEC Filing on Google Icon
5/16/2023State Street Corp739,352$3.02M0.0%+4.9%0.898%Search for SEC Filing on Google Icon
5/16/2023Squarepoint Ops LLC71,443$0.29M0.0%-27.7%0.087%Search for SEC Filing on Google Icon
5/16/2023Geode Capital Management LLC790,837$3.23M0.0%+5.6%0.960%Search for SEC Filing on Google Icon
5/16/2023Graham Capital Management L.P.32,643$0.13M0.0%-71.1%0.040%Search for SEC Filing on Google Icon
5/15/2023Schonfeld Strategic Advisors LLC11,000$45K0.0%-64.4%0.013%Search for SEC Filing on Google Icon
5/15/2023Cubist Systematic Strategies LLC67,793$0.28M0.0%-51.2%0.082%Search for SEC Filing on Google Icon
5/15/2023Two Sigma Advisers LP368,800$1.51M0.0%+11.9%0.448%Search for SEC Filing on Google Icon
5/15/2023Two Sigma Investments LP342,022$1.40M0.0%+22.5%0.415%Search for SEC Filing on Google Icon
5/15/2023Deutsche Bank AG238,516$0.97M0.0%-2.2%0.290%Search for SEC Filing on Google Icon
5/15/2023Price T Rowe Associates Inc. MD46,963$0.19M0.0%+16.9%0.057%Search for SEC Filing on Google Icon
5/15/2023XTX Topco Ltd61,512$0.25M0.1%N/A0.075%Search for SEC Filing on Google Icon
5/12/2023Renaissance Technologies LLC329,500$1.34M0.0%-4.1%0.400%Search for SEC Filing on Google Icon
5/12/2023Candriam S.C.A.152,187$0.57M0.0%-59.5%0.185%Search for SEC Filing on Google Icon
5/12/2023BlackRock Inc.4,106,142$16.75M0.0%-1.3%4.986%Search for SEC Filing on Google Icon
5/12/2023BNP Paribas Arbitrage SNC41,823$0.17M0.0%+49.3%0.051%Search for SEC Filing on Google Icon
5/12/2023Bank of America Corp DE84,036$0.34M0.0%+54.2%0.102%Search for SEC Filing on Google Icon
5/12/2023HRT Financial LP124,904$0.51M0.0%N/A0.152%Search for SEC Filing on Google Icon
5/12/2023Grantham Mayo Van Otterloo & Co. LLC26,300$0.11M0.0%N/A0.032%Search for SEC Filing on Google Icon
5/12/2023Dimensional Fund Advisors LP463,898$1.89M0.0%-15.3%0.563%Search for SEC Filing on Google Icon
5/12/2023Panagora Asset Management Inc.29,676$0.12M0.0%-81.0%0.036%Search for SEC Filing on Google Icon
5/12/2023Charles Schwab Investment Management Inc.325,124$1.33M0.0%-0.9%0.395%Search for SEC Filing on Google Icon
5/11/2023Acadian Asset Management LLC938,434$3.82M0.0%+61.5%1.139%Search for SEC Filing on Google Icon
5/10/2023Credit Suisse AG37,582$0.15M0.0%+8.6%0.046%Search for SEC Filing on Google Icon
5/10/2023Swiss National Bank61,700$0.25M0.0%-6.2%0.075%Search for SEC Filing on Google Icon
5/10/2023Connor Clark & Lunn Investment Management Ltd.194,151$0.79M0.0%+25.7%0.236%Search for SEC Filing on Google Icon
5/8/2023Federated Hermes Inc.173,388$0.71M0.0%N/A0.211%Search for SEC Filing on Google Icon
5/4/2023Barclays PLC44,077$0.18M0.0%-36.9%0.054%Search for SEC Filing on Google Icon
5/3/2023Jump Financial LLC36,400$0.15M0.0%N/A0.044%Search for SEC Filing on Google Icon
4/28/2023SG Americas Securities LLC21,460$88K0.0%+49.3%0.026%Search for SEC Filing on Google Icon
4/24/2023Mackenzie Financial Corp12,783$52K0.0%N/A0.016%Search for SEC Filing on Google Icon
4/14/2023Raymond James Financial Services Advisors Inc.35,407$0.14M0.0%-33.7%0.043%Search for SEC Filing on Google Icon
2/16/2023Alliancebernstein L.P.59,500$0.30M0.0%+54.1%0.073%Search for SEC Filing on Google Icon
2/15/2023Public Employees Retirement System of Ohio49,424$0.25M0.0%N/A0.060%Search for SEC Filing on Google Icon
2/15/2023Jane Street Group LLC31,724$0.16M0.0%N/A0.039%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
NGM Biopharmaceuticals logo
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company develops NGM707, an immunoglobulin-like transcript 2/ immunoglobulin-like transcript 4 dual antagonist monoclonal antibody that is in Phase I/II clinical trials for the treatment of patients with advanced metastatic solid tumors; and Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trials for the treatment of primary sclerosing cholangitis and non-alcoholic steatohepatitis. It also develops NGM120, an GFRAL antagonist antibody, which is in Phase II clinical trial to treat hyperemesis gravidarum; NGM831 and NGM438 which is in phase I/II clinical trial for the treatment of advanced solid tumors; and NGM621, an monoclonal antibody in Phase II clinical trials for the treatment of geographic atrophy. The company has research collaboration, product development, and license agreements with Merck Sharp & Dohme Corp.; and a collaboration agreement with Merck to focus primarily on the identification, research and development of collaboration compounds directed to targets in the fields of ophthalmology and cardiovascular or metabolic, or CVM, disease, including heart failure. NGM Biopharmaceuticals, Inc. was incorporated in 2007 and is headquartered in South San Francisco, California.
Read More on NGM Biopharmaceuticals

Today's Range

Now: $1.59
Low: $1.56
High: $1.60

50 Day Range

MA: $1.53
Low: $1.28
High: $1.92

52 Week Range

Now: $1.59
Low: $0.60
High: $4.69

Volume

357,138 shs

Average Volume

994,833 shs

Market Capitalization

$132.70 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.26

Who are the company insiders with the largest holdings of NGM Biopharmaceuticals?

NGM Biopharmaceuticals' top insider shareholders include:
  1. Group L P Column (Director)
  2. Jin-Long Chen (Insider)
  3. David V Goeddel (Director)
Learn More about top insider investors at NGM Biopharmaceuticals.

Who are the major institutional investors of NGM Biopharmaceuticals?

NGM Biopharmaceuticals' top institutional shareholders include:
  1. Vanguard Group Inc. — 3.35%
  2. Vanguard Group Inc. — 3.35%
  3. Federated Hermes Inc. — 0.42%
  4. GSA Capital Partners LLP — 0.40%
  5. BNP Paribas Financial Markets — 0.27%
  6. Bridgeway Capital Management LLC — 0.24%
Learn More about top institutional investors of NGM Biopharmaceuticals stock.

Which major investors are selling NGM Biopharmaceuticals stock?

During the last quarter, NGM stock was sold by these institutional investors:
  1. Federated Hermes Inc.
  2. Goldman Sachs Group Inc.
  3. Goldman Sachs Group Inc.
  4. Russell Investments Group Ltd.
  5. Bridgeway Capital Management LLC
  6. Dimensional Fund Advisors LP

Which major investors are buying NGM Biopharmaceuticals stock?

During the last quarter, NGM stock was acquired by institutional investors including:
  1. BNP Paribas Financial Markets
  2. GSA Capital Partners LLP
  3. Barclays PLC
  4. Exchange Traded Concepts LLC
  5. Mackenzie Financial Corp
  6. Vanguard Group Inc.
  7. Vanguard Group Inc.
Within the last year, these company insiders have bought NGM Biopharmaceuticals stock:
  1. Group L P Column (Director)
  2. Jin-Long Chen (Insider)
Learn More investors buying NGM Biopharmaceuticals stock.